Pharmaceutical composition used for inflammation anaphylaxis skin diseases
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- TEACHING HOSPITAL OF CHENGDU UNIV OF T C M
- Publication Date
- 2019-10-08
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention specifically relates to a pharmaceutical composition for inflammatory allergic skin diseases. Background technique
[0002] Inflammatory allergic skin diseases are skin diseases caused by allergens. Specific allergens can be divided into four categories: contact allergens, inhalation allergens, ingestion allergens, and injection allergens. Each type of allergen can cause corresponding allergic skin diseases, the main manifestations are various dermatitis, eczema, and urticaria.
[0003] Eczema is an inflammatory allergic skin disease characterized by recurrent attacks and severe itching. It often occurs in children and adults. About 18% of children and 5% of adults worldwide suffer from eczema. Its clinical symptoms are mainly manifested as erythema, exfoliation of the epidermis, and even lichenification, which seriously affects the healthy life of patients. Modern research has found that eczema is closely related to allergy, inflammati...